Clinical Trial Update: Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating substituting insulin glargine for TZD, sulfonylurea, or metformin in triple therapy for adults with Type 2 diabetes; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED | Results posted: 2010-02-19